The U.S. Food and Drug Administration’s decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of the participants in a clinical trial.
Getting Started is Easy and Yes It's FREE
What is The Ecosystem?
The Token Revolution.
The Next Bitcoin Moment.
